United States Neurological Diagnostic and Monitoring Equipment Market Outlook to 2033 - Electrical Activity Testing and ICP Monitoring Devices

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Neurological Diagnostic and Monitoring Equipment Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Neurological Diagnostic and Monitoring Equipment Market, United States, Revenue ($m), 2018-2033
3.1.1 Electrical Activity Testing Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 ICP Monitoring Devices Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Neurological Diagnostic and Monitoring Equipment Market, United States, Volume (Units), 2018-2033
3.2.1 Electrical Activity Testing Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 ICP Monitoring Devices Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Neurological Diagnostic and Monitoring Equipment Market, United States, Average Price ($), 2018-2033
3.4 Neurological Diagnostic and Monitoring Equipment Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Neurological Diagnostic and Monitoring Equipment Market, United States, Company Share by Revenue ($m), 2023

4.1 Natus Medical Inc
4.1.1 Company Overview
4.2 Nihon Kohden Corp
4.2.1 Company Overview
4.3 Medtronic Plc
4.3.1 Company Overview
4.4 Integra LifeSciences Corp
4.4.1 Company Overview
4.5 Masimo Corp
4.5.1 Company Overview
4.6 The Magstim Co Ltd
4.6.1 Company Overview
4.7 Cadwell Industries Inc
4.7.1 Company Overview
4.8 Raumedic AG
4.8.1 Company Overview
4.9 Moberg Research Inc
4.9.1 Company Overview
4.10 Sophysa SA
4.10.1 Company Overview

6.1 Asset Transactions
6.1.1 MPOWERHealth Acquires Certain Assests of IONM Business from Assure Holdings for USD4.5 Million
6.2 Debt Offerings
6.2.1 GE HealthCare Technologies Raises USD1 Billion in Public Offering of 4.800% Senior Notes Due 2029
6.3 Equity Offerings
6.3.1 GE HealthCare Technologies to Raise Funds in Secondary Offering of Shares
6.3.2 GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares

7.1 Financial Announcements
7.1.1 Dec 12, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025
7.1.2 Dec 04, 2024: NeuroOne to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time
7.1.3 Sep 26, 2024: Integer Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024
7.1.4 Jul 15, 2024: Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024
7.2 Government and Public Interest
7.2.1 Feb 10, 2025: GE Healthcare Management to Present at Upcoming Investor Conference
7.3 Product News
7.3.1 Dec 17, 2024: Adnexus Biotechnologies Unveils Neural Temporal Fingerprinting for Personalized Health Monitoring Using Artificial Intelligence
7.3.2 Oct 03, 2024: Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024
7.3.3 Aug 23, 2024: New Study Lights Path for Early Detection of Schizophrenia and Other Psychotic Disorders
7.3.4 Mar 25, 2024: A study led by IBEC successfully mimics the complex neuroblastoma vasculature on a chip to explore treatments for this pediatric cancer
7.4 Strategy And Business Planning
7.4.1 Jan 14, 2025: Neurogen Biomarking Launches Collaboration With Linus Health
7.4.2 Oct 29, 2024: Brook Health and Linus Health Revolutionize Cognitive Care: Same-Day Assessment and Treatment Now a Reality

8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 The Publisher's Consulting
8.3 Contact the Publisher
8.4 Disclaimer

Table 1: Neurological Diagnostic and Monitoring Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Electrical Activity Testing Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: ICP Monitoring Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Neurological Diagnostic and Monitoring Equipment Market, United States, Volume (Units), 2018-2033
Table 5: Electrical Activity Testing Market, United States, Volume (Units), 2018-2033
Table 6: ICP Monitoring Devices Market, United States, Volume (Units), 2018-2033
Table 7: Neurological Diagnostic and Monitoring Equipment Market, United States, Average Price ($), 2018-2033
Table 8: Neurological Diagnostic and Monitoring Equipment Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 9: Neurological Diagnostic and Monitoring Equipment Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 10: Neurological Diagnostic and Monitoring Equipment Market Pipeline Products
Table 11: MPOWERHealth Acquires Certain Assests of IONM Business from Assure Holdings for USD4.5 Million
Table 12: GE HealthCare Technologies Raises USD1 Billion in Public Offering of 4.800% Senior Notes Due 2029
Table 13: GE HealthCare Technologies to Raise Funds in Secondary Offering of Shares
Table 14: GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares
Table 15: Total Number of Primary Research Participants, Neurology Devices Market, by Country

Figure 1: Neurological Diagnostic and Monitoring Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Electrical Activity Testing Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: ICP Monitoring Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Neurological Diagnostic and Monitoring Equipment Market, United States, Volume (Units), 2018-2033
Figure 5: Electrical Activity Testing Market, United States, Volume (Units), 2018-2033
Figure 6: ICP Monitoring Devices Market, United States, Volume (Units), 2018-2033
Figure 7: Neurological Diagnostic and Monitoring Equipment Market, United States, Company Share (%) 2023